The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia

By sjmartinez • February 18, 2024

Sauve K, Watson A, Oh JT, Swift S, Vila-Farres X, Abdelhady W, Xiong YQ, LeHoux D, Woodnutt G, Bayer AS, Schuch R. The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093/infdis/jiae027. Epub ahead of print. PMID: 38366561.

Tags: ESKAPE pathogens, Harbor UCLA, Infectious Diseases, Lysin, multidrug-resistance, pneumonia, pseudomonas aeruginosa, Publications, synergy

Inflammatory markers and calcification of coronary arteries, aorta and cardiac valves: Findings from the atherosclerosis risk in communities study

Avula V, Mok Y, Ejiri K, Van't Hof J, Whelton SP, Hoogeveen RC, Ballantyne CM, Budoff MJ, Blaha MJ, Matsushita K. Inflammatory markers and calcification[...]

Doxycycline Postexposure Prophylaxis for Bacterial STIs: Prescribing Patterns, Use, Short-term Outcomes Among 2083 Patients in a Los Angeles Federally Qualified Health Care Program, and Implications for Widespread Use

Osmundson J, Holloway IW, Macias Gil R, Jann JT, Hong C, Bolan RK. Doxycycline Postexposure Prophylaxis for Bacterial STIs: Prescribing Patterns, Use, Short-term Outcomes Among[...]

Characteristics of Virtual Pulmonary Rehabilitation Programs in the United States: Results from a National Electronic Survey

Moy ML, Corn J, Kizziar A, Kaye R, Dorney Koppel GA, Bhatt SP, Casaburi R, Desiato JT, Garvey C. Characteristics of Virtual Pulmonary Rehabilitation Programs[...]